SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

60 DEGREES PHARMACEUTICALS, INC.
Date: July 10, 2025 · CIK: 0001946563 · Accession: 0001213900-25-062836

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-288550

Date
July 10, 2025
Author
H.C. WAINWRIGHT & CO., LLC
Form
CORRESP
Company
60 DEGREES PHARMACEUTICALS, INC.

Letter

Re: 60 Degrees Pharmaceuticals, Inc.

July 10, 2025

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street

NE Washington, D.C. 20549

Registration Statement on Form S-1

File No. 333-288550

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), H.C. Wainwright & Co., LLC ("Wainwright"), as placement agent on a best-efforts basis, hereby joins 60 Degrees Pharmaceuticals, Inc. in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-288550) (the "Registration Statement") to become effective on Monday, July 14, 2025, at 5:15 p.m., Eastern Time, or as soon as practicable thereafter. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

[Signature Page Follows]

Very truly yours,
H.C. WAINWRIGHT & CO., LLC

Show Raw Text
CORRESP
 1
 filename1.htm

 July 10, 2025

 VIA EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation
Finance

 100 F Street

 NE Washington, D.C. 20549

 Re:
 60 Degrees Pharmaceuticals, Inc.

 Registration Statement on Form S-1

 File No. 333-288550

 Ladies and Gentlemen:

 In accordance
with Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), H.C. Wainwright & Co., LLC ("Wainwright"),
as placement agent on a best-efforts basis, hereby joins 60 Degrees Pharmaceuticals, Inc. in requesting that the Securities and Exchange
Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-288550) (the "Registration Statement")
to become effective on Monday, July 14, 2025, at 5:15 p.m., Eastern Time, or as soon as practicable thereafter. Wainwright affirms that
it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

 [Signature Page Follows]

 Very truly yours,

 H.C. WAINWRIGHT & CO., LLC

 By:

 Name:
 Edward D. Silvera

 Title:
 Chief Operating Officer

 [Signature Page to Acceleration Request]